Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan
· Delayed Price · Currency is TWD 184.50
-3.50 (-1.86%)
Sep 26, 2025, 2:38 PM CST
TPE:6919 Market Cap
TPE:6919 has a market cap or net worth of 286.16 billion as of September 29, 2025. Its market cap has increased by 220.21% in one year.
Market Cap
286.16B
Enterprise Value
276.77B
Revenue
44.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
184.50
Market Cap Chart
Since December 26, 2022, TPE:6919's market cap has increased from 7.96B to 286.16B, an increase of 3,495.73%. That is a compound annual growth rate of 267.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 286.16B | 203.25% |
| Dec 31, 2024 | 94.36B | 300.87% |
| Dec 29, 2023 | 23.54B | 212.69% |
| Dec 30, 2022 | 7.53B | -5.41% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 189.36B |
| Bora Pharmaceuticals Co., LTD. | 84.40B |
| Lotus Pharmaceutical | 67.06B |
| Lumosa Therapeutics | 48.18B |
| Oneness Biotech | 32.14B |
| Polaris Group | 28.58B |
| Center Laboratories | 27.60B |
| Pegavision | 24.57B |